Help patients stay ahead
Know more sooner—providing optimal care and meeting goals
Following the American Diabetes Association (ADA) recommendations for diagnostic testing of diabetes helps ensure you provide optimum patient care as well as meet key performance measures.1-3
Our comprehensive panels help take the guesswork out of guidelines-based testing, so you and your patients can easily adhere to the recommended type and frequency of testing.
Our panels include:
- Diabetes, Newly Diagnosed and Monitoring Panel
Combines all tests recommended by ADA guidelines into one panel3
- Diabetes, Advancing Chronic Kidney Disease (CKD) Management Panel
Combines all tests recommended by ADA guidelines into one panel for patients with diabetes and stage 3 or 4 CKD3
- Nonalcoholic Fatty Liver Disease (NAFLD) Fibrosis Score Panel
Identifies diabetes patients who are at risk for developing serious liver disease (fibrosis score calculated at no additional cost)
Let us help you know what’s ahead
Contact a Quest Diagnostics Sales Representative to learn more
Want to learn more about the NAFLD Fibrosis Score Panel?
1 National Committee for Quality Assurance. Comprehensive diabetes care: the HEDIS measure. Available at:
diabetes-care. Accessed April 5, 2017.
2 Medicare.gov. Star ratings. Available at: medicare.gov/find-a-plan/staticpages/rating/
planrating-help.aspx. Accessed November 18, 2014.
3 Standards of medical care in diabetes—2017. Diabetes Care. 2017;40(Suppl 1):S1-S135.